Arvinas, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARVN research report →
About the company
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins. The company's pipeline features several promising candidates.
- CEO
- Randy Teel
- IPO
- 2018
- Employees
- 430
- HQ
- New Haven, CT, US
Price Chart
- Market Cap
- $541.33M
- P/E
- -2.43
- P/S
- 6.06
- P/B
- 1.39
- EV/EBITDA
- -2.14
- Div Yield
- 0.00%
- Gross Margin
- 97.43%
- Op Margin
- -279.31%
- Net Margin
- -247.54%
- ROE
- -44.39%
- ROIC
- -46.80%
- Revenue
- $262.60M · -0.30%
- Net Income
- $-80,800,000 · 59.38%
- EPS
- $-1.28 · 53.79%
- Op Income
- $-114,900,000
- FCF YoY
- -5.59%
- 52W High
- $14.51
- 52W Low
- $6.06
- 50D MA
- $8.82
- 200D MA
- $10.68
- Beta
- 1.75
- Avg Volume
- 846.81K
Get TickerSpark's AI analysis on ARVN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 24, 26 | Smaldone Alsup Laurie | other | 15,527 |
| Jun 24, 26 | Smaldone Alsup Laurie | other | 22,714 |
| Jun 24, 26 | Norwalk Leslie V | other | 15,527 |
| Jun 24, 26 | Norwalk Leslie V | other | 22,714 |
| Jun 24, 26 | Morrison Briggs | other | 15,527 |
| Jun 24, 26 | Morrison Briggs | other | 22,714 |
| Jun 24, 26 | Kennedy Edward Moore Jr. | other | 15,527 |
| Jun 24, 26 | Kennedy Edward Moore Jr. | other | 22,714 |
| Jun 24, 26 | Cunningham Everett | other | 15,527 |
| Jun 24, 26 | Cunningham Everett | other | 22,714 |
Our ARVN coverage
Recent articles, reports, and earnings notes.
No research on ARVN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARVN report →Similar companies
Peers in the same neighborhood.